Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?
Pasinetti
Giulio Maria
GM
Neuroinflammation Research Laboratories, Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA. giulio.pasinetti@mssm.edu
Pompl
Patrick Nicholas
PN
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D026661:Clinical Trials Data Monitoring Committees / Q000592:standards*; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence / Q000592:standards*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D018579:Patient Selection / Q000941:ethics*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D011451:Prostaglandin-Endoperoxide Synthases